Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
Cardiff University
Procurement Services, McKenzie House, 30-36 Newport Road
Cardiff
CF24 0DE
UK
Telephone: +44 2920879648
E-mail: Paynterjk@cardiff.ac.uk
NUTS: UKL
Internet address(es)
Main address: http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0258
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
GeoMX Spatial Profiler and nCounter MAX
Reference number: CU.786.JP
II.1.2) Main CPV code
38432000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The nanoString GeoMx Digital Spatial Profiler and nCounter Max combination is a novel cutting-edge technology which enables spatially resolved, digital characterisation of proteins or mRNA in tissue specimens, in highly multiplexed assays. The use of highly multiplexed assays combined with precise spatial information is leading to fundamental changes in how tissue samples are analysed within their 2D and 3D context. Importantly, the GeoMx also allows analysis of cultured cells and tissue as well as tissue sections, allowing modelling of in vitro interactions. As well as being integral to the GeoMX workflow, the nCounter can also be used as a powerful stand-alone single-cell analysis instrument.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
444 167.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
38432000
II.2.3) Place of performance
NUTS code:
UKL
II.2.4) Description of the procurement
The nanoString GeoMx Digital Spatial Profiler and nCounter Max combination is a novel cutting-edge technology which enables spatially resolved, digital characterisation of proteins or mRNA in tissue specimens, in highly multiplexed assays. The use of highly multiplexed assays combined with precise spatial information is leading to fundamental changes in how tissue samples are analysed within their 2D and 3D context. Importantly, the GeoMx also allows analysis of cultured cells and tissue as well as tissue sections, allowing modelling of in vitro interactions. As well as being integral to the GeoMX workflow, the nCounter can also be used as a powerful stand-alone single-cell analysis instrument.
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation:
The GeoMx Digital Spatial Profiler (DSP)
is only available from NanoString Technologies, Inc.
The GeoMx DSP is a novel digital technology (proprietary
to NanoString) that is based on multiplexed measurement
of protein and nucleic acids and offers unparalleled levels of
precision coupled with the ability to quantify up to 96 proteins
and over 1000 RNA targets on a formalin-fixed, paraffinembedded
(FFPE) tissue section on a microscope slide.
In contrast to the sequential analysis of multi-target
immunohistochemistry (IHC) slides, the GeoMx DSP samples
all protein or RNA analytes on a single slide. This not only
shortens experiments and simplifies data analysis, but also
provides a higher multiplexing capacity (96 targets) all with
spatial context from Formalin-Fixed, Paraffin-Embedded
(FFPE) tissue sections.
Based on NanoString’s proprietary digital barcoding
technology, the GeoMx DSP platform measures local protein
levels, and can be combined with RNA expression, within
heterogeneous tissue samples. Combining both multiplexed
nucleic acid and protein on the same platform gives
researchers the ability to spatially resolve RNA when suitable
antibodies do not exist. The GeoMx DSP assay is performed on
the GeoMx DSP platform which includes imaging and fluidic
components to capture spatial context, and current nCounter®
or next-generation sequencing (NGS) instruments provide the
quantification.
Protein detection is enabled via primary antibodies which
are covalently attached via a UV photocleavable linker to
DNA indexing oligos. Following antigen retrieval, FFPE tissue
samples are stained with a multiplexed cocktail of labeled
antibodies, and DNA oligos are subsequently released by
UV light exposure across regions of interest. The liberated
DNA oligos are then hybridized to optical barcodes for
quantitation on an nCounter or NGS instrument. This
technique enables quantitative, multiplexed protein detection
up to 5.5 logs of dynamic range
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: CU.786.JP
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
15/12/2021
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
NanoString Technologies
St. Marys Court, The Broadway
Amersham
HP70UT
UK
Telephone: +44 7468604366
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
444 167.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=116921.
(WA Ref:116921)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
17/12/2021